IL18 and lip and oral cavity carcinoma: Adjusted odds ratio (AOR) and 95% confidence intervals (CI) of clinical statuses associated with genotypic frequencies of IL-18 -607A/C and IL-18-137G/C in oral cancer patients (n=567).